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Pndovascular Therapy for Chronic Mesenteric Ischemia
ose A. Silva, MD, FACC,* Christopher J. White, MD, FACC,* Tyrone J. Collins, MD, FACC,*
. Stephen Jenkins, MD, FACC,* Malcolm E. Andry, MD,† John P. Reilly, MD, FACC,*
tephen R. Ramee, MD, FACC*
ew Orleans, Louisiana
OBJECTIVES We sought to describe the outcomes of a consecutive series of patients with chronic
mesenteric ischemia (CMI) who were treated with percutaneous stent revascularization.
BACKGROUND Historically, the treatment for CMI has been surgical revascularization. However, surgery
carries a significant procedural complication rate and mortality.
METHODS Fifty-nine consecutive patients with CMI underwent stent placement in 79 stenotic (70%)
mesenteric arteries. All patients had clinical follow-up and 90% had anatomical follow-up
with angiography (computed tomography or conventional) or ultrasound at 6 months after
the procedure.
RESULTS Procedural success was obtained in 96% (76 of 79 arteries) and symptom relief occurred in
88% (50 patients). At a mean follow-up of 38  15 months (range, 6 to 112 months), 79%
of the patients remained alive, and 17% (n  10) experienced a recurrence of symptoms.
Angiography or ultrasound obtained at 14  5 months after the procedure demonstrated a
restenosis rate of 29% (n  20). All patients with recurrent symptoms had angiographic
in-stent restenosis and were successfully revascularized percutaneously.
CONCLUSIONS Percutaneous stent placement for the treatment of CMI can be performed with a high
procedural success and a low complication rate. The long-term freedom from symptoms and
vascular patency are comparable with surgical results. The inherent lower procedural
morbidity and mortality makes the endovascular approach the preferred revascularization
technique for these patients. (J Am Coll Cardiol 2006;47:944–50) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.10.056College of Cardiology Foundation
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Tesenteric arterial stenosis is a common finding in elderly
atients with arteriosclerotic disease. Using duplex ultra-
ound, Hansen et al. (1) found that the prevalence of
ignificant (70% diameter stenosis) mesenteric artery ste-
osis in subjects older than 65 years of age was 17.5%.
hronic symptoms related to mesenteric arterial obstructive
isease, termed chronic mesenteric ischemia (CMI), are an
nusual clinical problem manifested by recurrent, debilitat-
ng abdominal pain, usually occurring after meals. In gen-
ral, patients with CMI commonly have stenoses or occlu-
ions of at least two or more mesenteric arteries, and this
ondition may lead to emaciation and death if left untreated
2,3). Historically, the treatment of this condition has been
urgical revascularization, with a perioperative complication
ate ranging between 33% and 47% and a 30-day mortality
ate of 8% to 12% (4,5).
Atherosclerotic mesenteric stenoses usually are focal and
ost often are located at the ostium or the very proximal
ortion of these vessels, which makes them technically
uitable for percutaneous transluminal intervention. Small
ase series have shown that, in selected patients, endovas-
ular therapy is a safe and effective treatment for this
ondition (6,7).
Aorto-ostial stenoses, in general, are difficult to treat with
alloon angioplasty alone because of the elastic recoil of the
ulky plaque after balloon dilation. In renal artery athero-
From the Departments of *Cardiology and †Medicine, Section of Gastroenterol-
gy, Ochsner Clinic Foundation, New Orleans, Louisiana.r
Manuscript received July 20, 2005; revised manuscript received September 21,
005, accepted October 3, 2005.clerotic aorto-ostial stenoses, the use of stents has been
hown to be superior to balloon angioplasty alone (8,9). It is
easonable to infer that the same may be true for the
reatment of mesenteric artery stenoses; however, there are
imited data in the literature addressing the role of percu-
aneous stent revascularization for the treatment of CMI
10,11). Therefore, the purpose of this report is to describe
he outcomes of a consecutive series of patients with CMI
reated with percutaneous stent revascularization.
ETHODS
atient population. From April 1993 until December of
004, 59 consecutive patients with symptomatic mesenteric
tenosis were treated endovascularly with primary stent
evascularization. The indications for the procedure and the
linical presentations were categorized as: 1) typical symp-
oms, manifested as postprandial abdominal pain, weight
oss, and/or “food fear” (12); 2) ischemic gastropathy,
anifested as nausea, vomiting, fullness, abdominal pain, or
eight loss (13); or 3) ischemic colitis, manifested as
bdominal pain, gastrointestinal bleeding, and/or hema-
ochezia (14). This retrospective review was approved by the
nvestigational review board of the Ochsner Clinic
oundation.
rocedure. Fifty-nine patients with 79 stenotic mesenteric
rteries were treated in 61 stent-revascularization proce-
ures. Stenosis of the target mesenteric artery was con-
rmed with nonselective or selective contrast arteriography.
he technique of mesenteric stent placement is similar toenal artery stent placement (15).
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March 7, 2006:944–50 Stent Placement for Chronic Mesenteric IschemiaRetrograde common femoral arterial access was used in
7% (n  47), and brachial artery access was employed in
3% (n 14) of the procedures. Aspirin was begun at least
ne day before the procedure, with the use of clopidogrel
eft at the operator’s discretion. Unfractionated heparin
as administered to maintain an activated clotting time
f 250 s.
utcomes. All patients were followed for at least six
onths. They were asked to return to the clinic at one-
onth and six-month intervals after the procedure. A
oninvasive imaging study (angiographic computed tomog-
aphy or a duplex ultrasound) to assess the patency of the
tent(s) was performed between six months and one year
fter the procedure, or sooner if symptoms returned. Quan-
itative measurement of the percent diameter stenosis of the
arget lesion was obtained from the invasive and noninvasive
i.e., computed tomography) angiograms (16), and esti-
ated from duplex ultrasound velocities (17).
efinitions. Primary stent placement was defined as the
ntention to deploy a stent in a target mesenteric vessel
efore the procedure, regardless of the angiographic result
fter balloon predilation. Angiographic success was defined
s a final diameter stenosis of30%, and procedural success
as defined as an angiographic success without an in-
ospital major complication. Major complications included
eath, myocardial infarction, stroke, need for emergent
urgical revascularization or in-hospital repeat target vessel
evascularization (TVR), atheroembolization, need for
lood transfusion, need for dialysis, or any vascular access
omplication that prolonged the hospital stay. Chronic renal
nsufficiency was defined as a creatinine 1.5 mg/dl. Re-
urrence of (ischemic) symptoms was defined as the reap-
earance of symptoms with similar pattern and characteris-
ics to those that occurred before stent placement.
estenosis was defined as: 1) a 50% diameter stenosis in
he follow-up angiography using computerized quantitative
ngiography (Image Comm Systems Inc., Mountain View,
alifornia); 2) 50% diameter stenosis by quantitative
ngiographic computed tomography (CTA) (16); or 3)
70% diameter stenosis by duplex ultrasound (17). Event-
ree survival was defined as freedom from death, recurrent
schemic symptoms, and TVR. Symptom relief was defined
s resolution of the presenting symptoms causing CMI, and
mprovement of symptoms was defined as the persistence of
ymptoms causing CMI although less intense, less frequent,
ith a different pattern, or as the persistence of some but not
Abbreviations and Acronyms
CMI  chronic mesenteric ischemia
CTA  angiographic computed tomography
SMA  superior mesenteric artery
TVR  target vessel revascularizationll of the original symptoms. ltatistical analysis. Categorical variables are reported as
requencies and percentages and continuous variables as
ean  standard deviation. Student t tests were used to
ompare continuous variables and chi-square tests were used
o compare categorical variables. Probability of survival and
ymptom-free survival were calculated using Kaplan-Meier
urvival curves (version 11.0, SPSS Inc., Chicago, Illinois).
ifferences at the level of p  0.05 (two-tailed) were
onsidered as statistically significant.
ESULTS
he baseline clinical characteristics of the patient popula-
ion are shown in Table 1.
linical presentation and angiographic characteristics.
orty-six patients (78%) presented with typical symptoms of
MI (Fig. 1, Table 2), eight patients (14%) presented with
ymptoms suggestive of ischemic gastropathy or celiac
erritory ischemic syndrome (Fig. 2), and five patients
8%) presented with ischemic colitis (confirmed colonos-
opy and biopsy) (Fig. 3). The angiographic characteris-
ics and results are shown in Table 3. The celiac artery
as treated in 47% (n  37), the superior mesenteric
rtery (SMA) in 40.5% (n  32), and the inferior
esenteric artery in 10% (n  8) of the cases. In addition,
ne vein graft and one common hepatic artery arising from
he aorta were also treated. Single vessel stenting was
erformed in 71% (n  41) and multivessel stent placement
n 29% (n  17) of the patients.
n-hospital outcomes. A total of 88 stents (85 balloon-
xpandable and 3 self-expandable stents) were successfully
mplanted in 77 mesenteric arteries. Angiographic success
as obtained in 97% (77 of 79 vessels), and procedural
uccess in 96% (76 of 79 vessels). One failure occurred in a
atient with chronic complete occlusion of all mesenteric
essels; attempts to cross the occlusions with a guidewire
ailed, and the patient was referred for surgical revascu-
able 1. Clinical Characteristics
n  59
ge, yrs 67  11
ender, female (%) 38 (64)
ypertension (%) 49 (83)
iabetes mellitus (%) 14 (24)
ypercholesterolemia (%) 55 (93)
urrent tobacco abuse (%) 25 (42)
oronary artery disease (%) 48 (81)
eripheral vascular disease (%) 40 (68)
RI (%) 16 (27)
enal artery stenosis (%)* 32 (54)
eurovascular disease (%) 20 (34)
EF 45  13 (range: 10 to 60)
EF 40 (%) 27 (46)
revious MI (%) 24 (41)
revious stroke (%) 7 (12)
50% diameter stenosis.
CRI  chronic renal insufficiency; EF  ejection fraction; MI  myocardial
nfarction.arization. The second failure was an in-hospital death of
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Stent Placement for Chronic Mesenteric Ischemia March 7, 2006:944–50malnourished diabetic patient with chronic renal insuf-
ciency who, after stenting, developed renal and multi-
rgan failure. Procedural complications included two
rachial arterial-access thromboses successfully treated
ercutaneously.
Symptom relief occurred in 88% (n  50) of the patients
ith a successful procedure (n  57). In seven patients, there
as partial or no symptom relief: three (5%) patients from
he group with typical symptoms and four patients (7%)
rom the ischemic gastropathy group.
There were four patients with angiographic evidence of
xtrinsic compression of the celiac artery by the arcuate
igament of the diaphragm (typical angiographic features),
nd one of these patients also had a severe stenosis of the
MA. One of these four patients presented with ischemic
olitis (Fig. 4), and the other three patients presented with
ostprandial abdominal pain (one had erosive gastritis). In
Figure 1. A 72-year-old male patient with t
able 2. Initial Clinical Presentation
n  59
bdominal pain (%) 59 (100)
ostprandial abdominal pain (%) 46 (78)
eight loss (%) 40 (68) (23  12 lbs)
ausea/vomiting/fullness (%) 13 (22)
iarrhea/constipation (%) 13 (22)
ematochezia/lower gastrointestinal 5 (8)mbleeding (%)ll four of these patients, the procedures were successful and
he symptoms were relieved after revascularization.
ollow-up. At a mean follow-up of 38  15 months
range, 6 to 112 months), of the 57 patients with a
uccessful procedure who left the hospital, 46 (81%) re-
ained alive. The 11 deaths were not related to recurrent
esenteric ischemia (Table 4), and seven patients had
natomical follow-up prior to their death.
Of the 57 patients (76 arteries) with a successful proce-
ure discharged from the hospital, anatomical follow-up
as available in 52 patients (91%) and 69 vessels (90%) at
4  5 months after the procedure (range, 6 to 26 months).
ngiography was obtained in 18 patients, CTA in 27
atients, and duplex ultrasound in 7 patients. In-stent
estenosis occurred in 20 of the 69 arteries (29%). There
ere no cases of in-stent occlusion, and only 10 patients
ith recurrence of symptoms required repeat percutaneous
evascularization.
The primary patency rate at 14 5 months was 71%, and
he primary assisted patency rate was 83%. There was no
ifference in the restenosis rate between the celiac artery
29%) and the SMA (30%; p  0.51). Recurrence of
schemic symptoms occurred in 10 (17%) patients at 6.8 
months after the procedure (range, 2 to 14 months). Nine
f these 10 patients (90%) had a single-vessel stent place-
symptoms of chronic mesenteric ischemia.ent. Symptom recurrence tended to be more frequent
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March 7, 2006:944–50 Stent Placement for Chronic Mesenteric Ischemiamong patients who underwent single-vessel revasculariza-
ion (24%), than in patients receiving more than one-vessel
evascularization (6%; p  0.09). In-stent restenosis was
onfirmed with angiography in every patient with symptom
ecurrence. In eight (80%) patients, recurrence of symptoms
ccurred in the first nine months after stent placement. The
igure 2. A 61-year-old woman with symptoms of ischemic gastropathy fo
esenteric artery was successfully recanalized and stented, with immediat
igure 3. A 67-year-old man with ischemic cardiomyopathy who develope
howed high grade stenosis of the celiac trunk and inferior mesenteric arteries,
ollow-up angiogram revealed patent mesenteric stents (last upper and lower pve-year probability of survival (72%), freedom from recur-
ence of symptoms (80%) and symptom-free survival (57%)
sing Kaplan-Meier survival analysis are shown in Figure 5.
The 10 patients with symptom recurrence (10 vessels)
nderwent TVR with balloon angioplasty alone (n  4),
alloon angioplasty and brachytherapy (n  3), or re-
e than one year and occlusion of all three mesenteric arteries. The superior
lution of her symptoms.
ominal pain and lower gastrointestinal bleeding. Mesenteric angiographyd abd
which were successfully stented with resolution of symptoms. A two-year
anels on the right).
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Stent Placement for Chronic Mesenteric Ischemia March 7, 2006:944–50tenting (n  3) with relief of symptoms. Of these 10
atients, 3 patients developed a second restenosis with
ecurrence of symptoms and were successfully treated with
alloon angioplasty; the other 7 patients have remained
symptomatic.
ISCUSSION
he use of percutaneous revascularization in the mesen-
eric circulation has been reported in small series with
elatively short follow-up. These studies have shown that
alloon angioplasty yields a high procedural success, with
ow morbidity and mortality rates, suggesting that endo-
ascular therapy is an important alternative treatment to
urgical revascularization in selected patients (6,7). There
re limited data describing endovascular stents for the
reatment of mesenteric stenosis (10,11). In a recent
tudy (11) of 25 patients and 26 arteries treated with
rimary stenting, technical success was obtained in 96%
nd relief of symptoms in 88%. There was no procedural
ortality, and the only complications were the develop-
ent of a pseudoaneurysm (n  2), and renal failure
n  1).
The present study constitutes the largest series of patients
ith CMI treated with a strategy of primary stent place-
able 3. Quantitative Angiography in 59 Patients and
9 Mesenteric Arteries
hree-vessel disease (%) 25 (42)
wo-vessel disease (%) 31 (53)
ne-vessel disease (%) 3 (5)
stial stenosis (%) 64 (81)
onostial stenosis (%) 15 (19)
hronic total occlusion (%) 4 (5)
VD baseline, mm 6.20  1.1
LD baseline, mm 1.26  0.4
DS baseline 80  6
VD postintervention, mm 6.21  1.1
LD postintervention, mm 5.82  1.0
DS postintervention 7  15
S  diameter stenosis; MLD  minimal lumen diameter; RVD  reference vessel
iameter.
igure 4. A 38-year-old woman with extrinsic compression of the celiac
efused surgical decompression and underwent successful stent placement w
can (last panel on the right) revealed50% in-stent restenosis but patency of th
t follow-up more than three years later.ent. The patient population had significant comorbidities,
ncluding coronary and peripheral vascular disease, as well as
schemic cardiomyopathy and, similar to previous reports,
ore than half of the patients had concomitant renal artery
tenosis (18). The diagnosis of CMI had been made by a
astroenterologist, primary care physician, and/or vascular
urgeon before the procedure, and in every case there was
onsensus to proceed with intervention. It is important to
tress the need for a multidisciplinary approach in the
reatment of this challenging condition (19). In this series,
2% of the patients did not have the classic presentation of
ntestinal angina and weight loss.
linical presentation and in-hospital outcomes. The
lassic triad of postprandial abdominal pain, weight loss,
nd fear for occurs in 50% to 70% of the patients (2). More
ecently, ischemic gastropathy (13,20,21), which is mani-
ested by nausea, vomiting, fullness, epigastric pain, weight
oss, and gastric ulcers, and ischemic colitis (14,22), which
resents as lower abdominal pain and diarrhea followed by
astrointestinal bleeding or hematochezia, have been shown
o be manifestations of CMI. In the present series, 14% of
he patients presented with ischemic gastropathy and 8%
ith ischemic colitis.
and history of crampy abdominal pain and bloody diarrhea. The patient
solution of symptoms. The six-month angiographic computed tomography
able 4. Overall Survival and Clinical Events of 58 Patients
ith Initial Angiographic Success
n  58
eath (%) 12 (21)
I 6
ancer* 4*
enal failure/sepsis 1
troke 1
esenteric ischemia 0
ecurrence of symptoms (%) 10 (17)
eath or recurrence of symptoms (%) 21 (36)
vent-free survival (%) 37 (64)
estenosis (%) by patient† 19 (37)*
estenosis (%) by vessel† 20 (29)*
One patient developed symptomatic in-stent restenosis 11 months before death;
reated successfully percutaneously. †A total of 52 patients and 69 vessels with
natomical follow-up at 14  5 months after the procedure.trunk
ith ree stent and no inspiratory collapse. She has had no recurrence of symptoms
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March 7, 2006:944–50 Stent Placement for Chronic Mesenteric IschemiaSymptom relief was obtained in 88%. Despite clinical
onsensus regarding the diagnosis and decision to proceed
ith intervention, it is likely that, in 12% of the patients,
MI was not the etiology or at least the only cause for the
atients’ symptoms.
ollow-up, late survival, and in-stent restenosis. The
ve-year cumulative freedom from death, symptom-
ecurrence, or both were 72%, 79%, and 57%, respectively
Fig. 5). These late results are comparable or in some cases
uperior to published surgical studies, which have reported
ortality rates of 31% to 48% and symptoms recurrence of
9% to 26.5% at a follow-up of three to five years
4,5,23,24).
A restenosis rate of 29% in the present study was
nexpected because, in renal arteries, which are anatomically
ery closely located, the reported restenosis rate after stent
lacement is in the low teens (9). This restenosis rate,
owever, is comparable with that found after surgical
ndarterectomy in which restenosis was found in 22% of 18
symptomatic patients tested with duplex ultrasound (5).
hether drug-eluting stents may have a favorable impact in
estenosis in the mesenteric arterial circulation remains
peculative.
Despite this angiographic restenosis rate, only 17% of
atients developed recurrent symptoms and required TVR.
t is likely that complete revascularization may have played
n important role in preventing symptom-recurrence be-
ause there was a trend toward less recurrence of symptoms
n patients with multivessel stenting (6%) compared with
ingle- vessel stenting (25%; p  0.09).
In no single case did the development of in-stent reste-
osis lead to mortality. Surgical studies have shown that
raft failure often presents abruptly as sudden occlusion,
ither in the early postoperative period or at follow-up,
eading to bowel infarction and death in the majority of
he patients (4,5,24). In contrast, none of our patients
igure 5. Kaplan-Meier survival curves showing the five-year cumulative
robability of survival, symptom-free, and symptom-free survival of the 59
atients.eveloped acute mesenteric ischemia, either early after
1he procedure or at follow-up. There were no acute or
ubacute post-procedural stent thrombosis events, and
he cases of in-stent restenosis led to gradual develop-
ent of symptoms.
tudy limitations. This is a single center retrospective
tudy and carries the inherent limitations of retrospective
ata analysis. In addition we did not directly compare
ndovascular treatment to surgical revascularization.
onclusions. In the largest series of CMI patients treated
ith endovascular therapy studied to date, we have shown
hat stent placement is a safe and effective revascularization
reatment. The long-term benefits and symptom-recurrence
ere comparable with those reported with surgical revascu-
arization but, in contrast to surgery, in no single case did
n-stent restenosis lead to acute mesenteric ischemia or
eath. On the basis of these results, we conclude that stent
evascularization should be considered as an alternative to
urgery in patients with CMI and the treatment of choice
or patients who are at increased risk for surgical com-
lications.
eprint requests and correspondence: Dr. Jose A. Silva, Depart-
ent of Cardiology, Ochsner Clinic Foundation, Slidell Clinic,
750 Gause Boulevard, Slidell, Louisiana 70461. E-mail: jsilva@
chsner.org.
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